摘要
目的:探讨戊四氮(PTZ)点燃大鼠海马结构白细胞介素1β(IL-1β)表达的特征及托吡酯(TPM)对其表达的影响。方法:将30只成年健康雄性SD大鼠随机分为3组,每组10只。模型组大鼠胃灌入生理盐水(10mL/kg)1h后腹腔注射10 g/L PTZ生理盐水溶液(35mg/kg);TPM组大鼠按40mg/kg胃灌注10g/L TPM生理盐水溶液,1h后腹腔注射PTZ(剂量同模型组);对照组大鼠按10 mL/kg和3.5 mL/kg分别胃灌注和腹腔注射生理盐水。各组每d给药1次。当模型组大鼠性发作行为达到点燃标准时,对大鼠的行为进行观察和记录,采用免疫组织化学方法对各组大鼠海马结构IL-1β的表达进行检测。结果:实验第4周,模型组大鼠达到点燃标准;而TPM组大鼠最高发作级别为3级,均未达点燃标准;对照组大鼠行为正常。与对照组比较,模型组和TPM组大鼠海马结构IL-1β表达增强(P<0.05);TPM组大鼠海马结构IL-1β的表达较模型组降低(P<0.05)。结论:癫大鼠免疫系统处于活化状态,TPM能降低PTZ点燃大鼠海马结构IL-1β的表达而对癫具有一定的抑制作用。
Aim: To explore the expressional character of interleukin-1β ( IL-1β) and the effect of topiramate(TPM) on its expression in the hippocampus of rats kindled by pentyleneterazol(PTZ). Methods: Thirty healthy male rats were randomly divided into three groups, ten in each group. The rats of group Ⅰ were given normal saline 10 mL/kg by gavage 1 h before intraperitoneal injection with 10 g/L PTZ at dose of 35 mg/kg daily. The rats of group Ⅱ were given 10 g/L TPM noral saline 40 mg/kg by garage 1 h before injection of 10 g/L PTZ at dose of 35 mg/kg daily. The rats of group Ⅲ (control group) were given the same amount of normal saline as other groups. When the spasm of rats in group Ⅰ reached kindling criterion, the behavior was observed and EEG was recorded, and immunohistochemistry was used to detect the IL-1β in the hippocampus of all rats. Results: The rats in group Ⅰ reached kindling criterion at Week 4, while the spasm scale of the rats in group Ⅱ was grade 3. Compared with that of group Ⅲ, IL-1β expression in the hippocampus of group Ⅰ and group Ⅱ significantly increased(P 〈 0.05). Furthermore, the IL-1β expression of group Ⅰ was higher than that of group Ⅱ (P 〈 0.05 ). Conclusion : The immune system of the epileptic rat was greatly activated, TPM can decrease the expression of IL-1β in the hippocampus of epileptic rats, which might provide some protective action through immunosuppression.
出处
《郑州大学学报(医学版)》
CAS
北大核心
2008年第3期440-442,共3页
Journal of Zhengzhou University(Medical Sciences)
基金
河南省科技攻关基金资助项目0124170634
郑州大学中青年骨干教师基金资助项目
郑州大学第一附属医院博士基金启动项目
郑州市科技攻关基金资助项目064SGD33218-20